The anthelmintic efficacy of the drug Expresstabs in helminthiasis of dogs

Abstract

The purpose of the research is to study the effectiveness of the drug ExpressTabs tested on dogs infected with helminths. The drug contains spinosad, praziquantel and moxidectin as active ingredients. Animals of mixed breeds of both sexes aged from 7 months to 2 years were selected for the experiments. Experimental and control groups of dogs with toxocariasis, toxascariasis and dipylidiasis were formed. ExpressTabs was administered to dogs individually, once, orally in a mixture with food or immediately after feeding (on the root of the tongue or with a treat) in a minimum dose of 30 mg of spinosad, 0.2 mg of moxidectin and 5 mg of praziquantel per 1 kg of animal weight. Animals in the control groups were not given tablets. A control examination in the case of dipylidiasis was carried out on the second day then if the animal continued to remain in the hospital once a week. For toxocariasis and toxascariasis fecal examination was carried out on day 7 then on days 14, 21 and 28. The drug ExpressTabs showed high (100%) effectiveness in the treatment of dogs with toxocariasis, toxaccariasis and dipylidiasis. In one animal re-infection with toxocariasis was observed because helminth eggs were again detected on day 28 in the control study. Taking into account the development cycle of parasites it is obvious that re-infection occurred no later than a week after the experimental deworming with ExpressTabs. At recommended doses the drug did not cause unwanted side effects.